Overview

A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.

Status:
Completed

Trial end date:
2008-08-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine the effects of the compound AZD7325 as compared to lorazepam on sleepiness, concentration and brain activity.

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Lorazepam